Acadian Asset Management’s LianBio American Depositary Shares LIAN Stock Holding History

Acadian Asset Management’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,605	Closed	-$65K	–	1851
2023 Q4	$65K	Sell	14,605 -166,539	-92%	-$573K	﹤0.01%	1429
2023 Q3	$268K	Buy	181,144 +38,808	+27%	+$73.9K	﹤0.01%	1145
2023 Q2	$323K	Buy	+142,336	New	+$327K	﹤0.01%	1165

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Acadian Asset Management's LIAN Position: Q1 2024 in Review

Acadian Asset Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 14,605 shares — an estimated $65K sold.

Acadian Asset Management first reported a position in LIAN in Q2 2023 and held it in 3 quarters. The position peaked at $323K in Q2 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Acadian Asset Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Acadian Asset Management sold 14,605 LianBio American Depositary Shares shares in Q1 2024, an estimated $65K.
Acadian Asset Management first reported a position in LianBio American Depositary Shares in Q2 2023 and held it in 3 quarters.
Acadian Asset Management's LianBio American Depositary Shares position peaked at $323K in Q2 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.